NUVL Nuvalent, Inc. Insider Trading

NUVL CFO Alexandra Balcom sells 11,430 shares across 8 transactions for $1,128,080.49 via pre-arranged plan.

Alexandra Balcom, CFO of Nuvalent, executed 8 separate sales totaling 11,430 shares for $1,128,080.49 on 2026-06-01, reducing her non-derivative holdings from 96,963 to 85,533 shares. This transaction was part of a pre-arranged 10b5-1 trading plan adopted on 2025-12-23, making it scheduled rather than discretionary. The blended average sale price of $98.69 compares to a current price of $90.18, with the stock down 20.2% from its 52-week high of $113.02 and down 12.1% over the past 30 days. Balcom retains 13,400 stock options and significant non-derivative holdings post-transaction, so her overall position remains material. The company's unprofitable status (net income of $-109,279,000.00) and recent negative momentum warrant attention to whether subsequent earnings or operational updates clarify the outlook.

CLO Deborah Ann Miller sold 5,500 shares at $107.84 avg for $593.1K via scheduled 10b5-1 plan on 2026-05-28

Deborah Ann Miller, Chief Legal Officer, executed 4 separate sales totaling 5,500 shares for $593,100.52 pursuant to a 10b5-1 trading plan adopted on 2024-11-18, reducing her non-derivative holdings from 65,134 shares to 59,634 shares. The stock currently trades at $93.01, down 17.7% from its 52-week high of $113.02, and Miller maintains derivative holdings of 72,608 stock options, preserving meaningful upside exposure. Nuvalent is unprofitable with net income of $-109,279,000.00 over its most recent full fiscal year, and her prior transactions at this ticker (5 prior sells) showed positive returns in both 30-day and 90-day windows following execution. As a scheduled transaction under a pre-arranged plan rather than a discretionary trade, this sale reflects a formulaic execution independent of current market conditions.

NUVL CEO Porter James Richard exercised 30K shares and immediately liquidated all 30K shares, netting $2.48M profit, in offsetting same-day transactions.

Porter James Richard, as President and CEO, executed a same-day exercise-and-sell transaction: acquiring 30,000 shares at $18.93 per share and immediately selling the entire position across five tranches at prices ranging up to $102.10. This represents his sixth through tenth open-market sales at NUVL in the trailing 36 months, adding to a track record of pure liquidation activity across his holdings. The timing is significant: four of his five prior sales at NUVL all occurred on the same date in early April and resulted in the stock subsequently falling, while his single earlier April sale proved poorly-timed as the stock rose. His current exercise-and-immediate-sell pattern is typical for option expiration management and carries no signal about conviction in the company's direction. The company is unprofitable with ongoing quarterly losses, and the stock currently trades modestly below its 52-week high, making this a straightforward liquidity event by the CEO rather than a statement about the business fundamentals.

CFO Balcom exercises vested options, immediately trims full position at elevated prices amid unprofitable financials.

CFO Alexandra Balcom exercised vested stock options and simultaneously sold all acquired shares—a classic liquidity harvest with zero net position change. The sale was executed at prices well above the exercise cost, netting over $1.1 million. However, this trade takes place within a company still burning cash with mounting losses, and the stock is trading meaningfully below its 52-week high, suggesting the CFO chose this window to monetize rather than hold. Balcom's prior sales at this stock have shown mixed timing: three of five previous exits were followed by stock declines (well-timed exits), while two saw subsequent rallies. This current sale—timed at prices near the 52-week high—follows her established pattern as a net seller and represents the sixth through eighth open-market sale at Nuvalent in the past three years. The structure itself (exercise-and-sell) is routine and reflects vesting schedules more than conviction, but the scale and context matter: a CFO liquidating her full position while the company posts consistent quarterly losses is a form of confidence exit that deserves attention.

Chief Legal Officer of unprofitable Nuvalent executes mixed transaction: small stock purchase offset by substantial sale near current levels

Deborah Ann Miller, Chief Legal Officer at Nuvalent, executed a complex three-part transaction on the same day: a modest stock purchase of approximately 5,500 shares paired with two separate sales totaling roughly 5,500 shares for a combined value exceeding $545,000. The timing is notable—the sales occurred at prices slightly above the current trading level, suggesting Miller locked in value near recent market expectations rather than capitulating during a deep decline. However, the company remains deeply unprofitable with significant operating losses, which typically constrains executive appetite for equity accumulation. The overall pattern reads less as insider conviction and more as routine rebalancing by an officer managing tax obligations or diversification needs, especially given that the buy and sell volumes nearly offset each other on the same date.